Deal Roundup: Bain Capital carves out Mitsubishi Tanabe Pharma at $3.3bn valuation, ACON completes Vitalis exit

Bain Capital has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma Corporation in a carve-out transaction from Mitsubishi Chemical Group Corporation.